Valiant Laboratories Limited has informed the Exchange that the Rights Issue Committee of the Company at its meeting held on July 15, 2025, has decided to issue equity shares on rights basis in the ratio of 1 : 4, i.e 1 Equity Shares for every 4 Equity Shares held. Issue Price is 75 per share.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories' Rights Issue Committee has approved a rights issue of up to 1,08,62,500 equity shares at ₹75 per share (face value ₹10 + premium ₹65), in the ratio of 1 share for every 4 shares held. The total issue size is about ₹81.47 crores, with the full amount payable on application. The record date is July 19, 2025, and the issue opens on July 28, 2025, closing on August 8, 2025. Pre-issue equity stands at around 4.34 crore shares, which will increase to about 5.43 crore shares if fully subscribed.
Shareholders on record date will receive rights entitlements to buy additional shares at ₹75 each, diluting existing holdings by about 25% if fully subscribed. The capital raised will strengthen the company's funds but existing investors will need to invest more to maintain their proportional ownership.